financetom
Business
financetom
/
Business
/
Billionaire Gautam Adani of India's Adani Group charged in US with bribery; bond deal pulled
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Billionaire Gautam Adani of India's Adani Group charged in US with bribery; bond deal pulled
Nov 20, 2024 11:27 PM

Nov 21 (Reuters) - Gautam Adani, the billionaire chair

of Indian conglomerate Adani Group and one of the world's

richest people, has been indicted in New York over his role in

an alleged multibillion-dollar bribery and fraud scheme,

according to U.S. prosecutors.

Authorities said Adani and seven other defendants, including

his nephew Sagar Adani, agreed to pay about $265 million in

bribes to Indian government officials to obtain contracts

expected to yield $2 billion of profit over 20 years, and

develop India's largest solar power plant project.

Fallout for the Adani empire was immediate.

Adani Green Energy cancelled plans on Thursday to

raise $600 million in U.S. dollar-denominated bonds, according

to four sources with direct knowledge of the matter. The bond

had been priced but was pulled following the news.

Adani Green Energy did not immediately respond to a request

for comment on the shelved transaction.

In early Asian trading on Thursday, Adani dollar bonds

slumped, with prices down between 3-5c on bonds for Adani Ports

and Special Economic Zone. The falls were the

largest since the Adani Group came under a short-seller attack

in February 2023.

The Adani Group has not responded to requests for comment on

the indictment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
Oct 17, 2024
Oct 14 (Reuters) - UK-based Cycle Pharmaceuticals on Monday reaffirmed its offer to buy Vanda Pharmaceuticals ( VNDA ) in a deal that values the US drugmaker at $488 million, despite a regulatory setback for its stomach condition drug in September. Vanda in June rejected takeover offers from Cycle Pharma and a revised bid from contract manufacturer Future Pak. WHY...
Market Chatter: HSBC Reviewing China Digital Wealth Business' Expenses, Control
Market Chatter: HSBC Reviewing China Digital Wealth Business' Expenses, Control
Oct 17, 2024
10:31 AM EDT, 10/14/2024 (MT Newswires) -- HSBC Holdings ( HSBC ) started a review of expenses and operational controls at its China digital wealth business Pinnacle a few months ago, Reuters reported Monday, citing several unnamed sources. The bank is looking into staff salary structures and whether suppliers inflated expenses, adding to a sharp increase in costs that exceeded...
Treace Medical Concepts Sues Stryker for Patent Infringement
Treace Medical Concepts Sues Stryker for Patent Infringement
Oct 17, 2024
10:41 AM EDT, 10/14/2024 (MT Newswires) -- Treace Medical Concepts ( TMCI ) said Monday it filed a lawsuit against Stryker (SYK) and its Wright Medical Technology subsidiary for allegedly infringing nine patents related to Treace's Lapiplasty 3D bunion correction technologies. The lawsuit, lodged in the US District Court for the District of New Jersey, seeks injunctive relief and damages,...
Affirm Holdings to Benefit From Lower Interest Rate Environment, Wedbush Securities Says
Affirm Holdings to Benefit From Lower Interest Rate Environment, Wedbush Securities Says
Oct 17, 2024
10:32 AM EDT, 10/14/2024 (MT Newswires) -- Affirm Holdings ( AFRM ) is set to benefit from a lower interest rate environment, leading to lower funding costs and incremental growth in gross merchandise volume, or GMV, among others, Wedbush Securities said in a note to clients early Monday. The company has a balanced risk/reward and a number of ancillary GMV...
Copyright 2023-2026 - www.financetom.com All Rights Reserved